Class-specific responses of brown adipose tissue to steroidal and nonsteroidal mineralocorticoid receptor antagonists
Vincenzo Marzolla(Vita-Salute San Raffaele University), Massimiliano Caprio(Vita-Salute San Raffaele University), Federica Limana(Vita-Salute San Raffaele University), Andrea Armani(Vita-Salute San Raffaele University), Peter Kolkhof(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Alessandra Feraco(Vita-Salute San Raffaele University)
Cited by 25
Related Papers
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
|European Heart Journal|2021|1.2k
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
|European Heart Journal|2013|573
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
|Journal of Endocrinological Investigation|2019|292
Assessing gender differences in food preferences and physical activity: a population-based survey
|Frontiers in Nutrition|2024|223